CMS' rule ending Medicaid and CHIP funding for pediatric sex-rejecting procedures is now in effect.
|Articles|November 1, 1998
Supplements and Featured Publications
- Chronic Viral Hepatitis in the Era of Managed Care
- Volume 4
- Issue 12 Suppl
Clinical Utility of HCV RNA Monitoring for Patients with Chronic Hepatitis C
Author(s)Lawrence M. Blatt, DrPH
Advertisement
Articles in this issue
almost 28 years ago
Participating Facultyalmost 28 years ago
An Overview of Viral Hepatitisalmost 28 years ago
Viral Hepatitis: Impact, Treatment, and Costsalmost 28 years ago
New Epidemiologic Data on Hepatitis B and Calmost 28 years ago
Appropriate Screening and Early Diagnosis of Hepatitis B and Calmost 28 years ago
State-of-the-Art Interferon Therapy for Chronic Viral Hepatitisalmost 28 years ago
Cost Effectiveness of Treating Chronic Hepatitis B and Calmost 28 years ago
Chronic Hepatitis C: An Overviewalmost 28 years ago
Chronic Hepatitis C: Impact, Diagnosis, and Treatmentalmost 28 years ago
Selected AbstractsAdvertisement
Related to this article
At a roundtable in Cleveland, kidney experts said IgA nephropathy and FSGS often go unrecognized, calling for EHR flags and better referral channels.
Labial gland biopsy may support diagnosis of neurologic Sjögren disease, especially when antibody tests are negative or inconclusive.
This analysis in RR MCL shows CAR T-cell therapy (brexucabtagene) yields higher complete responses vs bispecific antibodies; durability remains unclear.
Meta-analysis finds oral JAK inhibitors like baricitinib and ritlecitinib drive strong alopecia areata hair regrowth, improving SALT scores with manageable safety.
Follitropin delta yields cumulative ongoing pregnancy in 64.0% of patients under 35 and 43.9% of those 35 to 42 in 2 placebo-controlled IVF trials.
The Ambulatory Specialty Model aims to reduce chronic disease costs by mandating specialist participation and tying payments to quality and cost, while posing nationwide risk challenges.
Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
Advertisement
Advertisement
Trending on AJMC
1
Medicare Drug Price Negotiations Yield Uneven Out-of-Pocket Savings
2
CMS Rule Ends Medicaid, CHIP Funding for Pediatric Gender Care
3
Rusfertide Keeps Working Where Hydroxyurea Fades: Andrew Kuykendall, MD
4
Oral JAK Inhibitors Boost Hair Regrowth Odds in Alopecia Areata
5